Ascendis Pharma AS · ASND.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $1.30B − (Liabilities $1.46B + Equity -$162.75M) = -$1.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$615.78M
47.3%
$56.24M
10.1%
Assets
Receivables
$157.63M
12.1%
-$8.65M
-5.2%
Assets
Inventory
$301.40M
23.1%
$5.80M
2.0%
Assets
PPE
$146.42M
11.2%
$47.70M
48.3%
Assets
Other
$80.79M
6.2%
$21.44M
36.1%
Liabilities + Equity
Accounts payable
$90.62M
7.0%
-$5.78M
-6.0%
Liabilities + Equity
Short-term debt
$486.32M
37.4%
-$5.21M
-1.1%
Liabilities + Equity
Long-term debt
$385.25M
29.6%
$20.17M
5.5%
Liabilities + Equity
Other liabilities
$502.57M
38.6%
$170.38M
51.3%
Liabilities + Equity
Equity
-$162.75M
-12.5%
-$57.05M
-54.0%